Sponsored Links
| Health Canada Approves New Treatment Option For Canadians At High Risk Of Heart Attack Or Stroke |
 |
 |
 |
| Medical News - Heart Disease | |||
|
MICARDIS® (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme (ACE) inhibitor... Read more: Heart Disease News From Medical News Today
|